Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2012 Filed Jun 5, 2012 21:21 UTC |
Blaser Brian J.Executive Vice President
|
GrantOption (right to buy) · Derivative | 10,100 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001179110-12-009645 · edgar.xml · derivative · entry 2 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Underlying: Common shares · 10,100 shares Expires 2022-05-31 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 3,367 shares on 06/01/2013; 3,366 shares on 06/01/2014; and 3,367 shares on 06/01/2015. Read SEC document |
| June 01, 2012 Filed Jun 5, 2012 21:21 UTC |
Blaser Brian J.Executive Vice President
|
GrantCommon shares without par value | 5,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-009645 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,724 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| May 17, 2012 Filed May 18, 2012 21:03 UTC |
Blaser Brian J.Senior Vice President
|
Tax withholdingCommon shares without par value | 1,797 | $62.55 | $112,402.35 |
DisclosureSEC source: 0001179110-12-008676 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,224 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 49,235 | $0.00 Strike: $33.76 | $0.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · derivative · entry 16 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 49,235 shares Expires 2013-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Fully vested employee stock option received pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Rainforest Acquisition Inc. and Advanced Medical Optics, Inc. in exchange for an employee stock option to acquire 120,000 shares of Advanced Medical Optics, Inc. common stock for $13.85 per share. Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 700 | $62.63 | $43,841.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 15 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,147 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 600 | $62.62 | $37,572.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 14 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,847 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 1,600 | $62.61 | $100,176.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 13 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,447 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 519 | $62.60 | $32,489.40 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 12 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,047 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 400 | $62.59 | $25,036.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 11 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,566 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 800 | $62.58 | $50,064.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 10 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,966 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 4,197 | $62.57 | $262,606.29 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 9 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,766 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 400 | $62.56 | $25,024.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 8 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,963 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 2,400 | $62.55 | $150,120.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 7 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,363 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 4,719 | $62.54 | $295,126.26 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 6 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,763 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 4,200 | $62.53 | $262,626.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 5 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,482 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 11,000 | $62.52 | $687,720.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 4 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,682 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 17,600 | $62.51 | $1,100,176.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,682 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
SaleCommon shares without par value | 100 | $62.50 | $6,250.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,282 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC |
MAZZO JAMES VSenior Vice President
|
Exercise / conversionCommon shares without par value | 49,235 | $33.76 | $1,662,173.60 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2012 Filed May 4, 2012 21:05 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 25,602 | $0.00 Strike: $58.90 | $0.00 |
DisclosureSEC source: 0001179110-12-007791 · edgar.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 25,602 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| May 03, 2012 Filed May 4, 2012 21:05 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 24,705 | $62.65 | $1,547,768.25 |
DisclosureSEC source: 0001179110-12-007791 · edgar.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,443 Read SEC document |
| May 03, 2012 Filed May 4, 2012 21:05 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 25,602 | $58.90 | $1,507,957.80 |
DisclosureSEC source: 0001179110-12-007791 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:07 UTC |
TILTON GLENN FDirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007446 · edgar.xml · nonDerivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,206 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:08 UTC |
SCOTT SAMUEL C IIIDirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007447 · edgar.xml · nonDerivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,206 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:08 UTC |
NOVAKOVIC PHEBE NDirector
|
GrantOption (right to buy) · Derivative | 3,333 | $0.00 Strike: $62.10 | $0.00 |
DisclosureSEC source: 0001179110-12-007449 · edgar.xml · derivative · entry 2 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Underlying: Common shares · 3,333 shares Expires 2022-04-26 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:08 UTC |
NOVAKOVIC PHEBE NDirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007449 · edgar.xml · nonDerivative · entry 1 NOVAKOVIC PHEBE N · CIK 0001222195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,486 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:08 UTC |
OSBORN WILLIAM ADirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007448 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,476 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:09 UTC |
McKinstry NancyDirector
|
GrantOption (right to buy) · Derivative | 6,280 | $0.00 Strike: $62.10 | $0.00 |
DisclosureSEC source: 0001179110-12-007450 · edgar.xml · derivative · entry 2 McKinstry Nancy · CIK 0001294731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 Underlying: Common shares · 6,280 shares Expires 2022-04-26 F2 · security: Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:09 UTC |
McKinstry NancyDirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007450 · edgar.xml · nonDerivative · entry 1 McKinstry Nancy · CIK 0001294731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,819 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:09 UTC |
LIDDY EDWARD MDirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007451 · edgar.xml · nonDerivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,121 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:10 UTC |
Blount Sally E.Director
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007453 · edgar.xml · nonDerivative · entry 1 Blount Sally E. · CIK 0001537286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,819 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:10 UTC |
FARRELL W JAMESDirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007452 · edgar.xml · nonDerivative · entry 1 FARRELL W JAMES · CIK 0001021872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,333 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:11 UTC |
AUSTIN ROXANNE SDirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007454 · edgar.xml · nonDerivative · entry 1 AUSTIN ROXANNE S · CIK 0001061632 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,066 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 27, 2012 Filed May 1, 2012 21:11 UTC |
Alpern Robert JDirector
|
GrantCommon shares without par value | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-007455 · edgar.xml · nonDerivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,559 F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC |
White J. ScottSenior Vice President
|
SaleCommon shares without par value | 100 | $60.70 | $6,070.01 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 5 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,666 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC |
White J. ScottSenior Vice President
|
SaleCommon shares without par value | 700 | $60.70 | $42,490.00 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 4 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,766 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC |
White J. ScottSenior Vice President
|
SaleCommon shares without par value | 100 | $60.69 | $6,069.03 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,466 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC |
White J. ScottSenior Vice President
|
SaleCommon shares without par value | 3,833 | $60.69 | $232,624.77 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 2 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,566 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 21:21 UTC |
White J. ScottSenior Vice President
|
SaleCommon shares without par value | 6,635 | $60.68 | $402,611.80 |
DisclosureSEC source: 0001179110-12-007224 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,399 Read SEC document |
| April 06, 2012 Filed Apr 10, 2012 21:02 UTC |
GONZALEZ RICHARD AExecutive Vice President
|
Tax withholdingCommon shares without par value | 6,909 | $61.30 | $423,521.70 |
DisclosureSEC source: 0001179110-12-006676 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,575 Read SEC document |
| March 31, 2012 Filed Apr 3, 2012 21:02 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 538 | $61.29 Strike: $0.00 | $32,974.02 |
DisclosureSEC source: 0001179110-12-006273 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,265 Underlying: Common shares · 538 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2012 Filed Apr 3, 2012 21:03 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 538 | $61.29 Strike: $0.00 | $32,974.02 |
DisclosureSEC source: 0001179110-12-006274 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,668 Underlying: Common shares · 538 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2012 Filed Apr 3, 2012 21:03 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 513 | $61.29 Strike: $0.00 | $31,441.77 |
DisclosureSEC source: 0001179110-12-006277 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,538 Underlying: Common shares · 513 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2012 Filed Apr 3, 2012 21:04 UTC |
FULLER H LAURANCEDirector
|
GrantStock Equivalent Units · Derivative | 562 | $61.29 Strike: $0.00 | $34,444.98 |
DisclosureSEC source: 0001179110-12-006278 · edgar.xml · derivative · entry 1 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,966 Underlying: Common shares · 562 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2012 Filed Apr 3, 2012 21:04 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 128 | $61.29 Strike: $0.00 | $7,845.12 |
DisclosureSEC source: 0001179110-12-006281 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,014 Underlying: Common shares · 128 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 31, 2012 Filed Apr 3, 2012 21:05 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 128 | $61.29 Strike: $0.00 | $7,845.12 |
DisclosureSEC source: 0001179110-12-006282 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,014 Underlying: Common shares · 128 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,146 | $0.00 Strike: $54.05 | $0.00 |
DisclosureSEC source: 0001179110-12-006284 · edgar.xml · derivative · entry 8 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,146 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,649 | $0.00 Strike: $57.93 | $0.00 |
DisclosureSEC source: 0001179110-12-006284 · edgar.xml · derivative · entry 7 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,649 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,540 | $0.00 Strike: $54.03 | $0.00 |
DisclosureSEC source: 0001179110-12-006284 · edgar.xml · derivative · entry 6 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,540 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 30, 2012 Filed Apr 3, 2012 21:05 UTC |
Warmuth Michael JSenior Vice President
|
SaleCommon shares without par value | 13,335 | $61.16 | $815,568.60 |
DisclosureSEC source: 0001179110-12-006284 · edgar.xml · nonDerivative · entry 4 Warmuth Michael J · CIK 0001452290 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,286 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.